Lobbying client

MEDICINES360

To catalyze equitable access to medicines & devices

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
49
Filed by
3
Reported in-house
—
Reported by firms
$165,522

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2016 to 2026

Filings

4 filings for 2016, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2016
M.J. SIMON & COMPANY, LLC — reported
3rd Quarter - Amendment
3rd Quarter 2016
M.J. SIMON & COMPANY, LLC — reported
3rd Quarter - Reportreplaced
3rd Quarter 2016
M.J. SIMON & COMPANY, LLC $9,000 reported
Registration
3rd Quarter 2016
M.J. SIMON & COMPANY, LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
WAXMAN STRATEGIES 26 $105,522
G2G CONSULTING 7 $60,000
M.J. SIMON & COMPANY, LLC 9 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 35
Pharmacy PHA 4

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 2257 117th 7
H.R. 6071 115th 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.